The development of proteomics is a timely one for cardiovascular research.
Analyses at the organ, subcellular, and molecular levels have revealed dyna
mic, complex, and subtle intracellular processes associated with heart and
vascular disease. The power and flexibility of proteomic analyses, which fa
cilitate protein separation, identification, and characterization, should h
asten our understanding of these processes at the protein level. Properly a
pplied, proteomics provides researchers with cellular protein "inventories"
at specific moments in time, making it idea]. for documenting protein modi
fication due to a particular disease, condition, or treatment. This is acco
mplished through the establishment of species- and tissue-specific protein
databases, providing a foundation for subsequent proteomic studies. Evoluti
on of proteomic techniques has permitted more thorough investigation into m
olecular mechanisms underlying cardiovascular disease, facilitating identif
ication not only of modified proteins but also of the nature of their modif
ication. Continued development should lead to functional proteomic studies,
in which identification of protein modification, in conjunction with funct
ional data from established biochemical and physiological methods, has the
ability to further our understanding of the interplay between proteome chan
ge and cardiovascular disease.